Clinical Trials on Glucose Intolerance in India
Total 461 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Puerto Rico, United States, Romania, United Kingdom, Spain, Mexico, Austria, South Africa, Germany, Ukraine, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesKorea, Republic of, United Kingdom, Australia, Canada, Thailand, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, Argentina
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes MellitusUnited States, Argentina, India, Peru, Poland, Czech Republic
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Nutritional and Metabolic DiseasesUnited Kingdom, Germany, Belgium, Poland, India, Finland, Sweden, Netherlands, Russian Federation, Norway, Denmark
-
Eli Lilly and CompanyRecruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Astellas Pharma IncCompletedDiabetes Mellitus, Type 2United States, India, Philippines, Colombia, Mexico
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
-
AstraZenecaCompletedDiabetesTaiwan, United States, Russian Federation, India
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Public Health Foundation of IndiaNational Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaboratorsUnknownHypertension | Type 2 Diabetes Mellitus | DyslipidaemiaIndia, Pakistan
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Chronic Obstructive Pulmonary DiseaseSlovakia, Argentina, India, Turkey, Romania, Taiwan, Thailand
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Spain, Sweden, Malaysia, France, Netherlands, India, Argentina, South Africa, Romania, Former Serbia and Montenegro, Austria, Czech Republic, Philippines, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Russian Federation, United Kingdom, Taiwan, Argentina, Finland, Hungary, Macedonia, The Former Yugoslav Republic of, Malaysia, Mexico, Norway, Serbia, South Africa
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Greece, India, Philippines, Thailand, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Italy, Spain, Austria, Finland, Hungary, Turkey, France, United Kingdom, Switzerland, Bulgaria, Germany, South Africa, Former Serbia and Montenegro
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Russian Federation, Canada, Denmark, India, Poland, Korea, Republic of, Brazil, Argentina, Mexico, South Africa
-
SanofiCompletedDiabetes Mellitus, Type 2Austria, United Arab Emirates, Spain, Romania, Colombia, Korea, Republic of, Brazil, Greece, Italy, China, Denmark, India, Kuwait, Mexico, Taiwan, Turkey
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Chile, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Netherlands, Poland, United Kingdom, Argentina, Dominican Republic
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2Germany, Italy, Puerto Rico, Hungary, Mexico, United States, India, Portugal, Taiwan, Brazil, Poland
-
Eli Lilly and CompanyCompletedType 2 DiabetesChina, Australia, Korea, Republic of, India
-
PfizerCompletedType 2 Diabetes MellitusUnited States, Hungary, Taiwan, Romania, India, South Africa, Philippines, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Mexico, Argentina, Slovenia, Romania
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
TakedaCompletedDiabetes MellitusUnited States, Poland, Ukraine, Israel, Mexico, Romania, South Africa, Peru, Russian Federation, Hungary, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Netherlands, Russian Federation, India, Belgium, Japan, Romania, Italy
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Type 2 DiabetesUnited States, Malaysia, Peru, India, Argentina, Philippines, Romania, Ukraine
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Germany, Spain, Mexico, India, Canada, Greece, Thailand, United Kingdom, Finland, France
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Brazil, Puerto Rico, Canada, India, Denmark, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Denmark, Hungary, Slovenia, Switzerland, Bulgaria
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Spain, Russian Federation, Turkey, Austria, India, Korea, Republic of
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 1United States, Belgium, India, Italy, Argentina, France, Germany, Mexico, Puerto Rico
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Israel, Mexico, Poland, Canada, Austria, Belgium, Argentina, France, Bulgaria, Turkey
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, India, China, Brazil, Greece, Malaysia, Mexico, Philippines, Poland, Russian Federation
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Russian Federation, Puerto Rico, United Arab Emirates, Brazil